Deterioration of Respiratory Symptoms in Uncontrolled CPFE: A Case Report
Open Access
- 30 January 2025
- journal article
- Published by Universitas Airlangga in Jurnal Respirasi
- Vol. 11 (1) , 54-61
Abstract
Introduction: Chronic obstructive pulmonary disease (COPD) has a global impact on health and increases healthcare costs. Combined pulmonary fibrosis and emphysema (CPFE) combines interstitial lung disease (ILD) and emphysema. Excessive short-acting β2-agonist (SABA) usage escalates exacerbation risk, affecting prognosis. Case: A 44-year-old former smoker presented with worsening shortness of breath, cough, and weight loss. Examination showed respiratory distress, including wheezing. Initially, he was diagnosed with tuberculosis (TB) and COPD exacerbation. He regularly used jet nebulizers without medical supervision, and during the initial treatment, he developed acute respiratory failure, leading to acidosis. Treatment involved SABA and short-acting muscarinic-antagonist (SAMA), steroids, and oxygen therapy. In November 2023, his condition worsened, requiring emergency treatment. Radiological findings indicated CPFE. Management included nebulized medications, intravenous steroids, and antibiotics. Despite challenges, he rarely attended follow-up appointments after showing improvement, missing scheduled rehabilitation therapy, inhaler monitoring, comorbid therapy, and home oxygen monitoring. Conclusion: Combined pulmonary fibrosis and emphysema combines ILD and emphysema, causing severe respiratory impairment. Management mirrors that of COPD, involving inhalers, corticosteroids, and oxygen therapy.Keywords
This publication has 19 references indexed in Scilit:
- An increased risk of pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema: a meta-analysisBMC Pulmonary Medicine, 2023
- High use of short-acting β2-agonists in COPD is associated with an increased risk of exacerbations and mortalityERJ Open Research, 2023
- Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research StatementAmerican Journal of Respiratory and Critical Care Medicine, 2022
- Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice reviewPalliative Medicine, 2022
- COPD – do the right thingBMC Family Practice, 2021
- Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trialRespiratory Research, 2020
- Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programmeEuropean Respiratory Journal, 2020
- Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trialsEuropean Respiratory Journal, 2019
- Meta-analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary FibrosisChest, 2019